Which closed-end funds own Allogene Therapeutics Inc?
5 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $10.3M. Security type: common equity. Country: United States. CUSIP 019770106 · ISIN US0197701065 · ticker ALLO.
Holdings are historical filings (report dates May 29, 2026 – Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| HQL abrdn Life Sciences Investors | Healthcare | 0.82% | $5.7M | 2,731,752 sh | $690M | 3.4% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.27% | $3.7M | 1,770,000 sh | $1.4B | 7.1% discount | Jun 30, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.07% | $718K | 344,966 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.04% | $217K | 104,283 sh | $573M | 2.8% discount | Jun 30, 2026 |
| GUG Guggenheim Active Allocation Fund | U.S. Equity | 0.00% | $1.8K | 811 sh | $631M | 12.7% discount | May 29, 2026 |
5 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: ALLOGENE THERAPEUTICS INC.
Issuer-level search for “ALLO” → · Compare two funds’ portfolios →